This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a York University directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Evaluation of Low-Field NMR as a PAT Technology for Upstream Bioprocess Monitoring.
Pharmaceutical research · 2026
High-Affinity, Structure-Validated and Selective Macrocyclic Peptide Tools for Chemical Biology Studies of Huntingtin.
bioRxiv : the preprint server for biology · 2025
Author Correction: An abundant ginger compound furanodienone alleviates gut inflammation via the xenobiotic nuclear receptor PXR in mice.
Nature communications · 2025
Latest funding
- $880,000
Technology Enhanced Biopharmaceuticals Development and Manufacturing: Analytical
NSERC · 2025 · Principal investigator
- $200,000
Technology Enhanced Development, Manufacturing and Deployment
NSERC · 2024 · Co-investigator
- $43,000
Advancing Hydrogen Deuterium Exchange Mass Spectrometry to Explore the Dynamic Origins of Protein (mis)Function
NSERC · 2024 · Principal investigator
13 publications.
Evaluation of Low-Field NMR as a PAT Technology for Upstream Bioprocess Monitoring.
Gerzon G, Fischer C, Pennestri M, Hunter HN, Anklin C, Misra R, Wilson D, Sheng Y, Kirkitadze M
High-Affinity, Structure-Validated and Selective Macrocyclic Peptide Tools for Chemical Biology Studies of Huntingtin.
Wolf E, Fanti R, Ikenoue T, Deme JC, Balakrishnan S, Keith BA, Alteen MG, Chandrasekaran R, Yadav M, Bhajiawala R, Ackloo S, Feng J, Pouladi MA, Edwards AM, Wilson D, Lea SM, Suga H, Harding RJ
Author Correction: An abundant ginger compound furanodienone alleviates gut inflammation via the xenobiotic nuclear receptor PXR in mice.
Wang X, Zhang G, Bian Z, Chow V, Grimaldi M, Carivenc C, Sirounian S, Li H, Sladekova L, Motta S, Luperi Y, Gong Y, Costello C, Li L, Jachimowicz M, Guo M, Hu S, Wilson D, Balaguer P, Bourguet W, Mani S, Bonati L, Peng H, March J, Wang H, Wang S, Krause HM, Liu J
An abundant ginger compound furanodienone alleviates gut inflammation via the xenobiotic nuclear receptor PXR in mice.
Wang X, Zhang G, Bian Z, Chow V, Grimaldi M, Carivenc C, Sirounian S, Li H, Sladekova L, Motta S, Luperi Y, Gong Y, Costello C, Li L, Jachimowicz M, Guo M, Hu S, Wilson D, Balaguer P, Bourguet W, Mani S, Bonati L, Peng H, March J, Wang H, Wang S, Krause HM, Liu J
Quantitative Hydrogen-Deuterium Exchange Mass Spectrometry for Simultaneous Structural Characterization and Affinity Indexing of Single Target Drug Candidate Libraries.
Wolf E, Herasymenko O, Kutera M, Lento C, Arrowsmith C, Ackloo S, Wilson D
Diindoles produced from commensal microbiota metabolites function as endogenous CAR/Nr1i3 ligands.
Liu J, Malekoltojari A, Asokakumar A, Chow V, Li L, Li H, Grimaldi M, Dang N, Campbell J, Barrett H, Sun J, Navarre W, Wilson D, Wang H, Mani S, Balaguer P, Anakk S, Peng H, Krause HM
In vitro safety signals for potential clinical development of the anti-inflammatory pregnane X receptor agonist FKK6.
Dvořák Z, Vyhlídalová B, Pečinková P, Li H, Anzenbacher P, Špičáková A, Anzenbacherová E, Chow V, Liu J, Krause H, Wilson D, Berés T, Tarkowski P, Chen D, Mani S
Broadly neutralizing humanized SARS-CoV-2 antibody binds to a conserved epitope on Spike and provides antiviral protection through inhalation-based delivery in non-human primates.
Hermet P, Delache B, Herate C, Wolf E, Kivi G, Juronen E, Mumm K, Žusinaite E, Kainov D, Sankovski E, Virumäe K, Planken A, Merits A, Besaw JE, Yee AW, Morizumi T, Kim K, Kuo A, Berriche A, Dereuddre-Bosquet N, Sconosciuti Q, Naninck T, Relouzat F, Cavarelli M, Ustav M, Wilson D, Ernst OP, Männik A, LeGrand R, Ustav M
Multifunctional metallochaperone modifications for targeting subsite cavities in mutant p53-Y220C.
Miller JJ, Kwan K, Blanchet A, Orvain C, Mellitzer G, Smith J, Lento C, Nouchikian L, Omoregbee-Leichnitz S, Sabatou M, Wilson D, Gaiddon C, Storr T
Immunocartography: Charting vaccine-driven immunity by applying single cell proteomics to an in vitro human model.
Duprez JS, Cohen M, Li S, Wilson D, Brookes RH, James DA
Technology Enhanced Biopharmaceuticals Development and Manufacturing: Analytical
Principal investigators: Wilson, Derek
Keywords: Human pharmaceuticals
Technology Enhanced Development, Manufacturing and Deployment
Principal investigators: Wu, Jianhong J
Advancing Hydrogen Deuterium Exchange Mass Spectrometry to Explore the Dynamic Origins of Protein (mis)Function
Principal investigators: Wilson, Derek
Keywords: mass spectrometry; proteins; conformational dynamics; hydrogen deuterium exchange; protein dynamics; allostery; mechanism of action; analytical method; bioanalytical method; ion mobility
Technology-Enhanced Pharmaceutical Discovery (TEPD)
Principal investigators: Krylov, Sergey SN
Keywords: capillary electrophoresis; combinatorial libraries; dna-encoded library technology; drug discovery; high-throughput screening; hit-to-lead process; hit validation; mass spectrometry; vaccine development
Mathematical mobilization of vaccine development
Principal investigators: Heffernan, Jane
Keywords: mathematical immunology mathematical biology vaccine development adaptive immunity immune response vaccine adjuvants sensitivity analysis in-vitro and in-vivo machine learning
Microplastics in Sewage Sludge Exploration and Detection (MISSED)
Principal investigators: Brar, Satinder Kaur SK
Keywords: biofilm systems; breakdown products; characterization; chemistry; detection; fate and transport; microplastics; sewage sludge; suspended systems; wastewater
Conformational Disorder in Protein Function and Pathogenesis
Principal investigators: Wilson, Derek
Keywords: Allostery; Covalent labeling; Enzymes; Hydrogen Deuterium Exchange; Intrinsically Disordered Proteins; Mass Spectrometry; Metabolomics; Molecular Mechanisms of Neurodegenerative Disease; Protein Dynamics; Protein Interactions
Development of novel ß-catenin inhibitors as potential therapeutics for ovarian cancer
Principal investigators: Peng, Chun
Keywords: Ovarian Cancer; Small Molecule Inhibitors; Wnt/Beta-Catenin Signaling
Technology enhanced biopharmaceuticals development and manufacturing (TEnBioDev)
Principal investigators: Wilson, Derek DJ
Technology-enhanced biopharmaceuticals discovery and manufacturing (TBioDM)
Principal investigators: Wilson, Derek
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Hui Peng and Derek Wilson: 3 shared papers
- William Navarre and Hui Peng: 2 shared papers
- Henry Krause and Hui Peng: 2 shared papers
- Tim Storr and Derek Wilson: 2 shared papers
- William Navarre and Derek Wilson: 1 shared paper
- Cheryl Arrowsmith and Derek Wilson: 1 shared paper
- Cheryl Arrowsmith and Yi Sheng: 1 shared paper
- Henry Krause and Derek Wilson: 1 shared paper
- Derek Wilson and Yi Sheng: 1 shared paper
- Chemistry
- Department of Medical Biophysics
- Donnelly Centre
- Department of Molecular Genetics
- Biology
Co-authors at York University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Hui Peng
Chemistry
3 shared papers, latest 2025
Tim Storr
Chemistry
2 shared papers, latest 2023
Yi Sheng
Biology
1 shared papers, latest 2026
William Navarre
Department of Molecular Genetics
1 shared papers, latest 2024
Cheryl Arrowsmith
Department of Medical Biophysics
1 shared papers, latest 2024
Henry Krause
Donnelly Centre
1 shared papers, latest 2024
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.